
Pfizer Inc
PFENYSECIK 78003HealthcareFiscal year ends Dec 31
Reports and events: 369 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-03-2916:31 ET | 8-K | 8.01 Other events | 0001193125-22-088144 |
| 2022-03-2116:25 ET | SC 13D | Ownership report, active investor | 0000078003-22-000045 |
| 2022-03-1709:53 ET | DEF 14A | Proxy statementPeriod 2022-04-28 | 0000078003-22-000038 |
| 2022-02-2414:25 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000078003-22-000027 |
| 2022-02-0808:53 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-22-000003 |
| 2021-12-1516:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000078003-21-000118 |
| 2021-11-1916:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000078003-21-000114 |
| 2021-11-1206:06 ET | 10-Q | Quarterly reportPeriod 2021-10-03 | 0000078003-21-000107 |
| 2021-11-0208:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-21-000104 |
| 2021-09-1716:27 ET | SC 13D/A | Ownership report, active investor, amended | 0000078003-21-000099 |
| 2021-09-1716:17 ET | SC 13D/A | Ownership report, active investor, amended | 0000078003-21-000098 |
| 2021-08-1816:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-250347 |
| 2021-08-1216:01 ET | 10-Q | Quarterly reportPeriod 2021-07-04 | 0000078003-21-000093 |
| 2021-07-2808:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-21-000090 |
| 2021-07-0916:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000078003-21-000087 |
| 2021-07-0916:16 ET | SC 13D/A | Ownership report, active investor, amended | 0000078003-21-000083 |
| 2021-05-1311:32 ET | 10-Q | Quarterly reportPeriod 2021-04-04 | 0000078003-21-000065 |
| 2021-05-0408:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-21-000062 |
| 2021-04-2609:30 ET | 8-K | 5.07 Shareholder vote results | 0000078003-21-000059 |
| 2021-03-1209:32 ET | DEF 14A | Proxy statementPeriod 2021-04-22 | 0000078003-21-000047 |
| 2021-02-2513:59 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000078003-21-000038 |
| 2021-02-0213:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-21-000003 |
| 2021-01-1215:59 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-21-006923 |
| 2020-12-1422:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-317074 |
| 2020-11-2023:38 ET | 8-K | 2.01 Completion of an acquisition or disposition; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-298356 |
| 2020-11-1821:32 ET | 8-K | 8.01 Other events | 0001193125-20-296989 |
| 2020-11-1621:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-294847 |
| 2020-11-1322:05 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-293176 |
| 2020-11-0621:10 ET | SC 13D | Ownership report, active investor | 0000078003-20-000074 |
| 2020-11-0521:57 ET | 10-Q | Quarterly reportPeriod 2020-09-27 | 0000078003-20-000070 |
| 2020-11-0521:42 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-286896 |
| 2020-10-3021:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-282739 |
| 2020-10-2712:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-20-000065 |
| 2020-08-0621:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-212094 |
| 2020-08-0620:10 ET | 10-Q | Quarterly reportPeriod 2020-06-28 | 0000078003-20-000060 |
| 2020-07-2812:28 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-20-000056 |
| 2020-06-2621:03 ET | 8-K | 8.01 Other events | 0001193125-20-181098 |
| 2020-06-0121:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-20-157434 |
| 2020-05-2820:31 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-154311 |
| 2020-05-2220:44 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-150192 |
| 2020-05-1920:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-20-146185 |
| 2020-05-0714:42 ET | 10-Q | Quarterly reportPeriod 2020-03-29 | 0000078003-20-000037 |
| 2020-04-2812:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000078003-20-000034 |
| 2020-04-2416:38 ET | 8-K | 5.07 Shareholder vote results | 0000078003-20-000031 |
| 2020-04-0213:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000078003-20-000029 |
| 2020-03-2721:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000930413-20-000918 |
| 2020-03-1320:30 ET | DEF 14A | Proxy statementPeriod 2020-04-23 | 0000930413-20-000781 |
| 2020-03-0417:26 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000078003-20-000021 |
| 2020-03-0220:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000078003-20-000019 |
| 2020-02-2801:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000078003-20-000016 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 18:08 ET. Listed shows no prices and gives no investment advice.